Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Androgenetic alopecia doesn't increase the risk of heart-related health issues.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Baricitinib is effective for severe alopecia areata but has some side effects.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Surgery for burn scar alopecia often involves multiple procedures, and treatment options should be more accessible to improve self-image.

Neck burn scar contracture recurrence is more likely with larger neck defects, and closer follow-up can help detect it sooner.

Having an appendectomy may increase the risk of developing alopecia areata.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Skin cancer in sun-exposed areas is more likely to come back.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

Vaccination helps reduce long COVID symptoms in women with PCOS.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Standardized treatment protocols are needed for children with androgenetic alopecia.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Ultraviolet techniques help identify Grover’s Disease, which may be underdiagnosed in young people and females.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

People with atopic dermatitis have a higher risk of developing keloids, especially women, those under 40, and those with severe symptoms.